Annabelle Yoon

Escalation to biologics after corticosteroids in patients with newly diagnosed Crohn’s disease in Japan: a claims analysis from 2010 to 2021

Minoru Matsuura, Annabelle Yoon, Jun Miyoshi, Tadakazu Hisamatsu

BACKGROUND/AIMS: A previous health insurance claims study of Japanese patients with newly diagnosed Crohn's disease (CD) reported an increase in "step-up" approach from 2010 to 2020, with biologic use in the first year remaining stable. This study examined systemic corticosteroid (SCS) use …

jp (code pays fourni par la source)

Real-world use of biologics during the first year of treatment for newly diagnosed Crohn’s disease in Japan: a claims analysis from 2010 to 2021

Jun Miyoshi, Annabelle Yoon, Minoru Matsuura, Tadakazu Hisamatsu

BACKGROUND/AIMS: Crohn's disease (CD) leads to bowel damage and disability if suboptimally treated. We investigated firstyear treatment decisions and real-world use of biologics in patients with CD in Japan. METHODS: In this retrospective observational study (2010-2021) from the JMDC claims database, patients …

jp (code pays fourni par la source)

Multi-national observational study to assess quality of life and treatment preferences in patients with Crohn’s perianal fistulas

Chitra K. Karki, Amod S. Athavale, Vijay Abilash, Gary L. Hantsbarger et autres

BACKGROUND Patients with Crohn’s disease (CD) are at risk of developing complications such as perianal fistulas. Patients with Crohn’s perianal fistulas (CPF) are affected by fecal incontinence (FI), bleeding, pain, swelling, and purulent perianal discharge, and generally face a higher treatment burden …

us, jp, ch, gb, au, be (code pays fourni par la source)

EP1028: HIGH SYMPTOM BURDEN AND IMPACT ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CROHN'S PERIANAL FISTULAS: RESULTS FROM A GLOBAL BURDEN OF ILLNESS STUDY

Chitra K. Karki, Emily Elizabeth Sharpe, Gary L. Hantsbarger, Kate Lee et autres